Immunotherapy in NMSC: Bringing the Data to Life

Activity Overview

This activity features an interprofessional, multidisciplinary panel of experts offering privileged insights on immunotherapy in advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC). Uniquely, this evidence-based discussion is augmented by perspectives from a patient panelist sharing key aspects of their own treatment journey.

0.50 CE Credit(s)
Expires: December 6, 2023

Target Audience

Medical oncology and dermatology clinicians

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Assess current clinical evidence for immunotherapy-based treatment of advanced nonmelanoma skin cancers (NMSC)
  • Integrate immunotherapy in the management of advanced CSCC and BCC

Activity Faculty

Nikhil I. Khushalani, MD (Chair)

Nikhil I. Khushalani, MD (Chair)

Vice Chair and Senior Member
Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, FL

Gina Corsanico, ARNP

Gina Corsanico, ARNP

Moffitt Cancer Center
Tampa, FL

Anokhi Jambusaria, MD, MSCE

Anokhi Jambusaria, MD, MSCE

Associate Professor, Internal Medicine
Division of Dermatology
Dell Medical School
Austin, TX

Provider Statement

Provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources